文献速递细胞病理与分子病理神经与头颈病理

超声引导下细针穿刺鉴别甲状旁腺与甲状腺病变:临床数据、辅助检查与分子分析的相关性

Distinguishing parathyroid and thyroid lesions on ultrasound-guided fine-needle aspiration: A correlation of clinical data, ancillary studies, and molecular analysis.
PubMed 文献 · Cancer Cytopathol · 2017-06-16

该研究回顾2000至2016年143例临床 indeterminate 甲状腺结节,其中34例证实为甲状旁腺结节。识别出三种细胞学模式:嗜酸细胞型(9例,26%)、滤泡性病变未定意义样/乳头状样(14例,41%)和非特异内分泌细胞簇(11例,32%)。仅凭细胞学8例误诊为甲状腺,辅助检查(包括ThyroSeq v.2)纠正了诊断。

要点

  • 甲状旁腺病变细胞学可呈嗜酸细胞型、FLUS样/乳头状样或非特异内分泌细胞簇。
  • 裸卵圆核、核重叠、拥挤片状和胞内空泡是常见形态特征。
  • PTH免疫染色、PTH assay或ThyroSeq v.2有助于鉴别甲状旁腺与甲状腺。

核心结论

  • 具有FLUS样或嗜酸细胞特征的病变易误诊,识别特定细胞学模式联合PTH免疫染色、assay、分子研究或sestamibi扫描有助于鉴别甲状旁腺与甲状腺病变。

研究设计与样本

  • 回顾性研究,检索研究机构数据库2000至2016年临床 indeterminate 甲状腺结节,重点确认甲状旁腺结节,共143例,其中34例证实为甲状旁腺结节。

主要发现

  • 34例甲状旁腺结节中,嗜酸细胞型9例(26%),FLUS样/乳头状样14例(41%),非特异内分泌细胞簇11例(32%)。
  • 裸卵圆核100%、核重叠88%、拥挤片状88%、胞内空泡62%。
  • PTH免疫染色阳性10例(29%),PTH assay阳性7例(21%),ThyroSeq v.2检测PTH 9例(26%)。
  • 仅凭细胞学8例初诊为甲状腺组织,辅助检查后修正为甲状旁腺病变,其中5例仅基于ThyroSeq v.2结果。

关键数值与推荐

  • 细胞学模式:嗜酸细胞型、FLUS样/乳头状样、非特异内分泌细胞簇。
  • 形态特征:裸卵圆核、核重叠、拥挤片状、胞内空泡。
  • 辅助检查:PTH免疫染色、PTH assay、ThyroSeq v.2、sestamibi扫描。

临床怎么用

  • 对具有FLUS样或嗜酸细胞特征的甲状腺结节,应警惕甲状旁腺来源,联合PTH免疫染色、assay或分子检测以避免误诊。

局限性

  • 回顾性研究,样本来自单机构,甲状旁腺结节例数有限(34例)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Differentiating parathyroid and thyroid lesions can be challenging because of considerable morphologic overlap and anatomic proximity. Therefore, the authors sought to identify characteristic morphologic patterns and useful adjunct tests to distinguish these 2 entities. METHODS: A search was conducted in the study institution database for clinically indeterminate thyroid nodules from 2000 through 2016 with an emphasis on confirmed parathyroid nodules. Pathology reports, slides, ancillary studies, molecular analysis, and clinical and radiologic data were retrieved. RESULTS: A total of 143 cases of clinically indeterminate thyroid nodules were identified; 34 of these were confirmed parathyroid nodules. Three cytologic patterns were identified: 1) oncocytic cell pattern (9 cases; 26%); 2) follicular lesion of undetermined significance-like/papillary-like pattern (14 cases; 41%); and 3) nonspecific endocrine cell clusters (11 cases; 32%). Bare oval nuclei (100%), nuclear overlap (88%), crowded sheets (88%), and intracytoplasmic vacuoles (62%) were observed. Ten cases (29%) demonstrated positive immunostaining for parathyroid hormone (PTH), 7 cases (21%) demonstrated a positive PTH assay, and 9 cases (26%) had PTH detected by ThyroSeq v.2. The remaining 8 cases were morphologically either indeterminate or suggestive of parathyroid origin. The cytologic diagnosis was confirmed clinically (20 cases) or surgically (14 cases). Based on cytology alone, 8 cases initially were diagnosed as thyroid tissue and amended to parathyroid lesion after ancillary studies were performed, including 5 cases based on ThyroSeq v.2 results alone. CONCLUSIONS: Lesions with follicular lesion of undetermined significance-like or oncocytic features are prone to misdiagnosis. The current study identified distinct cytologic patterns in parathyroid lesions suggestive of parathyroid origin, which, together with PTH immunostains or assay, molecular studies, or sestamibi scans, aid in distinguishing parathyroid from thyroid lesions. Cancer Cytopathol 2017;125:674-82. © 2017 American Cancer Society.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Cho M, Oweity T, Brandler TC, et al. Distinguishing parathyroid and thyroid lesions on ultrasound-guided fine-needle aspiration: A correlation of clinical data, ancillary studies, and molecular analysis. Cancer Cytopathol. 2017. PMID: 28621914. doi:10.1002/cncy.21888

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。